Get the Stockscreener App
372.00
0.62%
-2.32
After Hours:
372.00
Medpace Holdings Inc stock is currently priced at $372.00, with a 24-hour trading volume of 213.64K.
It has seen a -0.62% decreased in the last 24 hours and a -4.62% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $378.2 pivot point. If it approaches the $370.1 support level, significant changes may occur.
Medpace Holdings Inc Stock (MEDP) Financials Data
Medpace Holdings Inc (MEDP) Revenue 2024
MEDP reported a revenue (TTM) of $1.89 billion for the quarter ending December 31, 2023, a +29.17% rise year-over-year.
Medpace Holdings Inc (MEDP) Net Income 2024
MEDP net income (TTM) was $282.81 million for the quarter ending December 31, 2023, a +15.26% increase year-over-year.
Medpace Holdings Inc (MEDP) Cash Flow 2024
MEDP recorded a free cash flow (TTM) of $396.73 million for the quarter ending December 31, 2023, a +12.97% increase year-over-year.
Medpace Holdings Inc (MEDP) Earnings per Share 2024
MEDP earnings per share (TTM) was $8.88 for the quarter ending December 31, 2023, a +21.31% growth year-over-year.
Medpace Holdings Inc Stock (MEDP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| BURWIG SUSAN E | Exec. VP, Operations |
Mar 15 '24 |
Sale |
403.00 |
102 |
41,106 |
15,181 |
| Keating Ashley M. | Director |
Mar 14 '24 |
Option Exercise |
84.36 |
500 |
42,180 |
500 |
| Keating Ashley M. | Director |
Mar 14 '24 |
Sale |
409.87 |
250 |
102,468 |
250 |
| Medpace Investors, LLC | 10% Owner |
Mar 08 '24 |
Sale |
408.71 |
25,000 |
10,217,750 |
4,733,019 |
| Troendle August J. | CEO |
Mar 08 '24 |
Sale |
408.71 |
25,000 |
10,217,750 |
4,733,019 |
| Keating Ashley M. | Director |
Mar 07 '24 |
Option Exercise |
54.99 |
472 |
25,955 |
472 |
| Medpace Investors, LLC | 10% Owner |
Mar 07 '24 |
Sale |
410.74 |
75,000 |
30,805,500 |
4,758,019 |
| Troendle August J. | CEO |
Mar 07 '24 |
Sale |
410.74 |
75,000 |
30,805,500 |
4,758,019 |
| Keating Ashley M. | Director |
Mar 07 '24 |
Sale |
415.00 |
472 |
195,880 |
0 |
| Medpace Investors, LLC | 10% Owner |
Mar 06 '24 |
Sale |
412.98 |
100,000 |
41,298,000 |
4,833,019 |
Medpace Holdings Inc Stock (MEDP) Latest News
CareDx (CDNA) Moves 5.5% Higher: Will This Strength Last?
Zacks Investment Research
Icon PLC (ICLR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Zacks Investment Research
Medpace (MEDP) Earnings Expected to Grow: Should You Buy?
Zacks Investment Research
Why HCA Healthcare (HCA) is a Smart Addition to Your Portfolio
Zacks Investment Research
Why You Should Add Ensign Group (ENSG) to Your Portfolio Now
Zacks Investment Research
Will Medpace (MEDP) Beat Estimates Again in Its Next Earnings Report?
Zacks Investment Research
About Medpace Holdings Inc
Medpace Holdings, Inc., a clinical contract research organization, provides scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries worldwide. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in a range of therapeutic areas. Its clinical development services include medical affairs, clinical trial management, feasibility and start-up study, clinical monitoring, global regulatory affairs, medical writing, biometrics, pharmacovigilance, core laboratory, and quality assurance. Medpace Holdings, Inc. was founded in 1992 and is headquartered in Cincinnati, Ohio.
COMPANY PROFILE
NameMedpace Holdings Inc
SectorHealthcare (1201)
IndustryDiagnostics & Research (65)
Webmedpace.com
Phone513-579-9911
Employee2,800
Twitter
@WorkatMedpace
SEC filings
Latest SEC Filings
Next earning date2024-04-22
Address5375 Medpace Way, Cincinnati, OH, United States (45227)
1.02%
1.23%
Cap:
|
Volume (24h):